N-(4-硝基苄基)环庚胺 | 355814-18-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-(4-硝基苄基)环庚胺
• 英文名称: N-(4-nitrobenzyl)cycloheptanamine
• 英文别名: N-[(4-nitrophenyl)methyl]cycloheptanamine
• CAS: 355814-18-5
• 化学式: C₁₄H₂₀N₂O₂
• mdl: MFCD01129753
• 分子量: 248.325
• InChiKey: JIFJLALKYPETLR-UHFFFAOYSA-N

物化性质

• 沸点：
  392.1±17.0 °C(Predicted)
• 密度：
  1.11±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.571
• 拓扑面积：
  57.8
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2921499090

反应信息

• 作为反应物：
  描述：

  N-(4-硝基苄基)环庚胺 在 三乙酰氧基硼氢化钠 、 tin(ll) chloride 作用下， 以 四氢呋喃 、 二氯甲烷 、 水 为溶剂， 反应 5.0h， 生成 3,4-dichloro-N-(4-((cycloheptyl(methyl)amino)methyl)phenyl)benzamide
  参考文献：
  名称：

  Potent and selective CC-chemokine receptor-2 (CCR2) antagonists as a potential treatment for asthma

  摘要：

  A number of compounds bearing a quaternary ammonium moiety were found to be antagonists with nanomolar binding affinity for the chemokine receptor-2. The structure-activity relationships in the series are described herein along with some detailed characterization of the interesting compounds. (c) 2007 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmcl.2007.01.115
• 作为产物：
  描述：

  环庚胺 、 对硝基苯甲醛 在 三乙酰氧基硼氢化钠 、 溶剂黄146 作用下， 以 二氯甲烷 为溶剂， 反应 6.0h， 生成 N-(4-硝基苄基)环庚胺
  参考文献：
  名称：

  Potent and selective CC-chemokine receptor-2 (CCR2) antagonists as a potential treatment for asthma

  摘要：

  A number of compounds bearing a quaternary ammonium moiety were found to be antagonists with nanomolar binding affinity for the chemokine receptor-2. The structure-activity relationships in the series are described herein along with some detailed characterization of the interesting compounds. (c) 2007 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmcl.2007.01.115

文献信息

• Compounds for increasing lipid synthesis and storage
  申请人：NUtech Ventures

  公开号：US10351883B2

  公开（公告）日：2019-07-16

  This invention relates to methods for increasing lipid accumulation and lipid production in cells. Methods of producing biofuel from cells and preparing nutraceuticals comprising lipids produced according to a method provided herein are also provided.

  本发明涉及增加细胞中脂质积累和脂质生产的方法。本发明还提供了从细胞中生产生物燃料的方法，以及制备包含根据本发明提供的方法生产的脂质的营养保健品的方法。
• Compounds for Increasing Lipid Synthesis and Storage
  申请人：NUtech Ventures

  公开号：US20160312253A1

  公开（公告）日：2016-10-27

  This invention relates to methods for increasing lipid accumulation and lipid production in cells. Methods of producing biofuel from cells and preparing nutraceuticals comprising lipids produced according to a method provided herein are also provided.
• Potent and selective CC-chemokine receptor-2 (CCR2) antagonists as a potential treatment for asthma
  作者：Bharat Lagu、Chrissy Gerchak、Meng Pan、Cuifen Hou、Monica Singer、Ravi Malaviya、Michele Matheis、Gil Olini、Druie Cavender、Michael Wachter

  DOI：10.1016/j.bmcl.2007.01.115

  日期：2007.8

  A number of compounds bearing a quaternary ammonium moiety were found to be antagonists with nanomolar binding affinity for the chemokine receptor-2. The structure-activity relationships in the series are described herein along with some detailed characterization of the interesting compounds. (c) 2007 Published by Elsevier Ltd.